Dengue vaccine (recombinant exosomes)(Ciloa SAS)

N/A

Report date: 2022/11/27 13:48:44

Base Information

Drug NameDengue vaccine (recombinant exosomes)(Ciloa SAS)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsDengue

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCiloa SAS

China Registration ClassN/A

Active CompaniesCiloa SAS

Inactive CompaniesN/A

Active IndicationsDengue

Inactive IndicationsN/A

ATC CodeN/A